TOP TIERMARKET NEWSWIRE
News & sentiment

TRAVERE THERAPEUTICS (TVTX) — News & AI sentiment

TRAVERE THERAPEUTICS (TVTX) news roundup. 2 stories in the past week, 10 over 30 days. Average 30-day sentiment is 58.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 11 sales totalling $80.1M — net selling of $80.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 57/100
30d stories
10
avg sentiment 58.6/100
Insider net (90d)
$80.1M
0 buys · 11 sells
Congress (90d)
0
0 buys · 0 sells

TVTX news in the last 24 hours, 7 days, 30 days and 90 days

How much TVTX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowTVTX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days257/100TVTX headlines →
Last 30 days1058.6/100TVTX headlines →
Last 90 days4055.8/100TVTX headlines →

Latest stories on TVTX

2d ago
5d ago
Oct 12
Oct 7
Oct 7
Oct 6
Oct 5
Oct 2
Oct 2
Sep 30
Sep 24
Guggenheim raises Travere Therapeutics stock price target on patent
Investing.com Analyst Ratings61 · neutralanalyst
Sep 24
Sep 23
Sep 22
Travere Therapeutics stock falls amid CEO transition news
Investing.com Markets42 · neutralgeneral
Sep 21
Sep 21
Sep 21
Sep 21
Sep 21
Sep 17
Sep 11
Sep 8
Aug 21
Travere Therapeutics: Valuation Suggests A Buy
Seeking Alpha63 · neutralanalyst
Aug 19
Aug 12
Open TVTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →